The equity markets are evolving quickly, and value investing is no longer king. Both Buffett and Munger made their fortunes in a different era of investing, where inefficient markets allowed for enormous opportunities in value prospects. Today, tech-driven growth investing has usurped value, leaving legacy investors twiddling their thumbs.

Check out my article:Warren Buffett's Value Investing Vs. Tech-Driven Growth,for more details.

Breakout Biotech Stocks with Triple-Digit Profit Potential

The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.

Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.

See these 7 breakthrough stocks now>>